Publikationen

Hoter, A., Das, A. M., & Naim, H. Y. (2025). Cellular uptake and function of recombinant pegunigalsidase alfa in fibroblasts from Fabry patients. In Molecular genetics and metabolism (108771). Elsevier BV. https://doi.org/10.1016/j.ymgme.2024.108771
Details anzeigen

Hoter, A., Tannous, S., Das, A. M., & Naim, H. Y. (2025). Membrane lipid composition regulates cellular binding and uptake of pegunigalsidase alfa across diverse cell types, including fabry fibroblasts: possible implications for multiorgan treatment. 15th International Congress of Inborn Errors of Metabolism (ICIEM2025), Kyoto (Japan), 02.-06.09.2025.
Details anzeigen

Lynch-Miller, M., Lockow, S., Dümmer, K., Henneck, T., Olmer, R., Jaboreck, M.-C., Mergani, A. O., Wandrey, M., Branitzki-Heinemann, K., Brogden, G., Naim, H. Y., Martin, U., Schulz, C., Talbot, S. R., Meurer, M., Baumgärtner, W., & von Köckritz-Blickwede, M. (2025). Characterization of 3D human pulmonary epithelial model morphology and oxygen status under normoxia and hypoxia. Biochimica et Biophysica Acta: Molecular Cell Research, 1872(6), Article 119980. https://doi.org/10.1016/j.bbamcr.2025.119980
Details anzeigen

Tannous, S., Husein, D. M., & Naim, H. Y. (2025). Congenital sucrase-isomaltase mutations worsen IBS-linked V15F dysfunction and trafficking. Gut: The Journal of the British Society of Gastroenterology. https://doi.org/10.1136/gutjnl-2025-336813
Details anzeigen

Tannous, S., & Naim, H. Y. (2025). Sucrase-isomaltase gene variants in irritable bowel syndrome: impact on protein trafficking and enzyme function. 15th International Congress of Inborn Errors of Metabolism (ICIEM2025), Kyoto (Japan), 02.-06.09.2025.
Details anzeigen

Torices, L., Bonfiglio, F., Esteban-Blanco, C., Zamfir-Taranu, A., Naim, H. Y., D’Amato, M., & D’Amato, M. (2025). Domain-specific effects of sucrase-isomaltase genotype in irritable bowel syndrome. Gastroenterology, 169(2), 346–348. https://doi.org/10.1053/j.gastro.2025.01.242
Details anzeigen

Zamfir-Taranu, A., Löscher, B.-S., Carbone, F., Hoter, A., Esteban Blanco, C., Bozzarelli, I., Torices, L., Routhiaux, K., Houte, K. V. d., Bonfiglio, F., Mayr, G., Corsetti, M., Naim, H. Y., Franke, A., Tack, J., & D’Amato, M. (2025). Functional variation in human CAZyme genes in relation to the efficacy of a carbohydrate-restricted diet in IBS patients. Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association, 23(7), 1228–1237. https://doi.org/10.1016/j.cgh.2024.09.004
Details anzeigen

Abi Sleiman, M., Younes, M., Hajj, R., Salameh, T., Abi Rached, S., Abi Younes, R., Daoud, L., Doumiati, J. L., Frem, F., Ishak, R., Medawar, C., Naim, H. Y., & Rizk, S. (2024). Urtica dioica: anticancer properties and other systemic health benefits from in vitro to clinical trials. International Journal of Molecular Sciences, 25(13), Article 7501. https://doi.org/10.3390/ijms25137501
Details anzeigen

El Khoury, M., & Naim, H. Y. (2024). Lipid rafts disruption by statins negatively impacts the interaction between SARS-CoV-2 S1 subunit and ACE2 in intestinal epithelial cells. Frontiers in Microbiology, 14, Article 1335458. https://doi.org/10.3389/fmicb.2023.1335458
Details anzeigen

El Khoury, M., Wanes, D., Lynch-Miller, M., Hoter, A., & Naim, H. Y. (2024). Glycosylation modulation dictates trafficking and interaction of SARS-CoV-2 S1 subunit and ACE2 in intestinal epithelial Caco-2 cells. Biomolecules, 14(5), Article 537. https://doi.org/10.3390/biom14050537
Details anzeigen